Portland, OR -- (SBWIRE) -- 07/06/2017 -- Snoring is the result of vibration of respiratory structures which leads to production of sound. The sound produced is the result of obstructed air movement during breathing while sleeping. Anti-snoring devices help in the reduction.
Early buyers will receive 20% customization on this report.
Technological advancements in anti-snoring devices market, growth in cigarette and alcohol consumption, rise in geriatric and obese population, and increase in awareness in developed countries about the ill effects of snoring and benefits of associated treatments drive the market. However, high cost of custom-made oral devices, and poor efficacy and lack of scientific validation of the anti-snoring devices currently available in the market restrain this growth. The growth opportunities in emerging economies of Asia-Pacific and LAMEA, and presence of a large untreated population base are expected to provide numerous opportunities for market growth during the forecast period.
The report segments the market based on product and geography. Based on product, the market is divided into oral appliances, nasal devices, position control devices, chin straps, tongue-stabilizing devices, and expiratory positive airway pressure (EPAP) therapy devices. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Get PDF of this Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2121
The major companies profiled in the report include Sleeping Well, LLC, Apnea Sciences Corporation, Somnomed Ltd., Airway Management Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, GlaxoSmithKline plc, and others.
Key Benefits for Stakeholders
-The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
-It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
-Extensive analysis by product helps understand the various types of nanomedicines used for treatment of chronic disorders.
-Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
-Key players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.
Anti-Snoring Devices Market Key Segments
a.Mandibular Advancement Devices (MADs)
a.External Nasal Dilators
b.Other Nasal Devices
3.Position Control Devices
6.Expiratory Positive Airway Pressure (EPAP) Therapy Devices
h.Inlays & Onlays
f.Rest of Europe
f.Rest of Asia-Pacific
d.Rest of LAMEA